Novo Nordisk Pens - Search News

News

Novo Nordisk Shares Tumble

Novo Nordisk shares plummet over 20% on weight-loss drug sale slump

The firm also named Maziar Mike Doustdar as its new CEO on Tuesday, after a gloomy financial forecast spooked investors. View on euronews

The Wall Street Journal on MSN · 6h

Novo Nordisk Shares Plummet as Competition Weighs on Sales

The pharma giant cut its guidance and named a new CEO, hoping to revive growth. Its stock fell as much as 30%, wiping almost $93 billion from its market value.

CNBC on MSN · 8h

Novo Nordisk shares plunge 23% after Wegovy maker names new CEO, cuts full-year guidance

Danish pharmaceutical giant Novo Nordisk on Tuesday named its new CEO and cut its full-year sales and profit guidance.

Fierce Pharma9h

Novo Nordisk names new CEO as the obesity drugmaker cuts sales, profit outlook

Novo Nordisk has named Maziar Mike Doustdar, currently the company’s EVP of international operations, as the new CEO.

Novo Nordisk outgoing CEO blames compounded GLP-1s for decline in 2025 outlook

The maker of GLP-1 drugs Ozempic and Wegovy cut sales grown from 13%-21% down to 8%-14% for the year. That's about half, on the higher end, of the 26% growth seen in 2024. Outgoing CEO Lars Jøregensen ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

News

Novo Nordisk Shares Tumble

Trending now